A CASE OF QT PROLONGATION AND TORSADES DE POINTES CAUSED BY IBOGAINE TOXICITY

被引：12
|
作者：
Hildyard, Catherine [1 ]
Macklin, Philip [2 ]
Prendergast, Bernard [3 ]
Bashir, Yaver [3 ]
机构：
[1] Oxford Deanery, Core Med Trainee, Oxford OX3 7LE, England
[2] John Radcliffe Hosp, Dept Emergency Med, Oxford OX3 9DU, England
[3] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England
来源：
JOURNAL OF EMERGENCY MEDICINE | 2016年 / 50卷 / 02期
关键词：
ADDICTION DRUG IBOGAINE; ACUTE OPIOID WITHDRAWAL;
D O I：
10.1016/j.jemermed.2015.06.051
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：E83 / E86
页数：4
相关论文
共 50 条
  • [21] QT Prolongation and Torsades de pointes associated with clarithromycin treatment
    Caccavo, Alberto
    Keegan, Roberto
    REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA, 2016, 45 (03): : 149 - 150
  • [22] QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF ANTIBIOTICS
    BAVOUX, F
    THERAPIE, 1992, 47 (05): : 367 - 369
  • [23] QT prolongation and Torsades de Pointes in patients previously treated with Anthracyclines
    Arbel, Yaron
    Swartzon, Michael
    Justo, Dan
    ANTI-CANCER DRUGS, 2007, 18 (04) : 493 - 498
  • [24] QT prolongation and torsades de pointes in a patient with heart block and a pacemaker
    Bernstein, Brett S.
    Silver, Eric S.
    Liberman, Leonardo
    CARDIOLOGY IN THE YOUNG, 2016, 26 (01) : 161 - 163
  • [25] Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone
    Atar, S
    Freedberg, NA
    Antonelli, D
    Rosenfeld, T
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (03): : 785 - 786
  • [26] Voriconazole-induced QT interval prolongation and torsades de pointes
    Aypar, Ebru
    Kendirli, Tanil
    Tutar, Ercan
    Ciftci, Ergin
    Ince, Erdal
    Ileri, Talia
    Atalay, Semra
    PEDIATRICS INTERNATIONAL, 2011, 53 (05) : 761 - 763
  • [27] QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
    Malone, Katie
    Hancox, Jules C.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2020, 11
  • [28] QT interval prolongation and the risk of torsades de pointes: essentials for clinicians
    Trinkley, Katy E.
    Page, Robert Lee, II
    Lien, Hoang
    Yamanouye, Kevin
    Tisdale, James E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) : 1719 - 1726
  • [29] Predicting drug-induced QT prolongation and torsades de pointes
    Roden, Dan M.
    JOURNAL OF PHYSIOLOGY-LONDON, 2016, 594 (09): : 2459 - 2468
  • [30] Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes
    Lin, Yeong-Liang
    Kung, Mei-Fen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (03) : 235 - 239
12345